US Patent 7396920 Tumour suppressor and uses thereof
Patent 7396920 was granted and assigned to Novartis on July, 2008 by the United States Patent and Trademark Office.
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Brian A Hemmings0
Sauveur-Michel Maira0
Edits on 14 Sep, 2023
Golden AI
Edits made to:
Article (+321 characters)
Article
Patent abstract
A human protein (designated Carboxy-terminal Modulating protein, CTMP) is described and is identified as having tumour suppressor properties. CTMP has been shown to interact with protein kinase B and inhibit protein kinase B activity, establishing its importance in the protein kinase B signalling pathway.
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07396920 Tumour suppressor and uses thereof US Patent 7396920 Tumour suppressor and uses thereof
Infobox
Patent Number
07396920
Patent Number
7396920
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 9 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 30 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07396920 Tumour suppressor and uses thereof
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07396920
Date of patent
July 8, 2008
Patent application number
10297641
Date Filed
June 7, 2001
Patent primary examiner
Find more entities like US Patent 7396920 Tumour suppressor and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
